{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:56:19Z","timestamp":1761807379339},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s12094-007-0130-4","type":"journal-article","created":{"date-parts":[[2007,12,14]],"date-time":"2007-12-14T08:21:04Z","timestamp":1197620464000},"page":"731-736","source":"Crossref","is-referenced-by-count":9,"title":["Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas"],"prefix":"10.1007","volume":"9","author":[{"given":"L.","family":"Pina-Cabral","sequence":"first","affiliation":[]},{"given":"L.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"B.","family":"Mesquita","sequence":"additional","affiliation":[]},{"given":"T.","family":"Amaro","sequence":"additional","affiliation":[]},{"given":"S.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[]},{"given":"B.","family":"Criado","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,12,15]]},"reference":[{"key":"130_CR1","first-page":"17","volume":"31","author":"S. Baithun","year":"1998","unstructured":"Baithun S, Daruwala P, Oliver RT (1998) Squamous changes in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer. Cancer Surv 31: 17\u201327","journal-title":"Cancer Surv"},{"key":"130_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/0019-5359.16298","volume":"59","author":"W. Yudong","year":"2005","unstructured":"Yudong W, Wang G, Wei J, Wen X (2005) Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer. Indian J Med Sci 59:235\u2013242","journal-title":"Indian J Med Sci"},{"key":"130_CR3","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.2741\/sharp","volume":"7","author":"J.D. Sharp","year":"2002","unstructured":"Sharp JD, Hausladen DA, Maher MG et al (2002) Bladder cancer detection with urinary survivin, an inhibitor of apoptosis. Frontiers Biosci 7:e36\u201341","journal-title":"Frontiers Biosci"},{"key":"130_CR4","first-page":"163","volume":"37","author":"H.G. Wiener","year":"1993","unstructured":"Wiener HG, Vooijs GP, Hof-Grootenboer BV (1993) Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37:163\u2013169","journal-title":"Acta Cytol"},{"key":"130_CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-5347(01)61899-8","volume":"161","author":"S. Ramakumar","year":"1999","unstructured":"Ramakumar S, Bhuiyan J, Besse JA (1999) Comparison of screening methods in the detection of bladder cancer. J Urol 161:388\u2013394","journal-title":"J Urol"},{"key":"130_CR6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ijc.21000","volume":"116","author":"S. Weikert","year":"2005","unstructured":"Weikert S, Christoph F, Schrader M et al (2005) Quantitative analysis of survivin mRNA expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116:100\u2013104","journal-title":"Int J Cancer"},{"key":"130_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.ju.0000106082.44786.3b","volume":"171","author":"J. Ku","year":"2004","unstructured":"Ku J, Kwak C, Lee H et al (2004) Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 171:631\u2013635","journal-title":"J Urol"},{"key":"130_CR8","first-page":"3327","volume":"23","author":"I.J. Schultz","year":"2003","unstructured":"Schultz IJ, Kiemeney LA, Witjes JA et al (2003) Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23:3327\u20133331","journal-title":"Anticancer Res"},{"key":"130_CR9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/01.ju.0000107826.78479.90","volume":"171","author":"S.F. Shariat","year":"2004","unstructured":"Shariat SF, Casella R, Khoddami SM et al (2004) Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 171:626\u2013630","journal-title":"J Urol"},{"key":"130_CR10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jama.285.3.324","volume":"285","author":"S.D. Smith","year":"2001","unstructured":"Smith SD, Wheeler MA, Plescia J et al (2001) Urine detection of survivin and diagnosis of bladder cancer. JAMA 285:324\u2013328","journal-title":"JAMA"},{"key":"130_CR11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM199908053410614","volume":"341","author":"H.S. Swana","year":"1999","unstructured":"Swana HS, Grossman D, Anthony JN et al (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452\u2013453","journal-title":"N Engl J Med"},{"key":"130_CR12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00432-004-0561-z","volume":"130","author":"H. Wang","year":"2004","unstructured":"Wang H, Xi X, Kong X, Ge GHG (2004) The expression and significance of survivin mRNA in urinary bladder carcinomas. J Cancer Res Clin Oncol 130:487\u2013490","journal-title":"J Cancer Res Clin Oncol"},{"key":"130_CR13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1373\/clinchem.2004.032003","volume":"50","author":"I.J. Schultz","year":"2004","unstructured":"Schultz IJ, Kiemeney LA, Karthaus HFM et al (2004) Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 50:1425\u20131428","journal-title":"Clin Chem"},{"key":"130_CR14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.ju.0000063685.29339.24","volume":"170","author":"D.A. Hausladen","year":"2003","unstructured":"Hausladen DA, Wheeler MA, Altieri DC et al (2003) Effect of intravesical treatment of transitional cell carcinoma with bacillus calmetteguerin and mitomycin C on urinary survivin levels and outcome. J Urol 170:230\u2013234","journal-title":"J Urol"},{"key":"130_CR15","volume-title":"International histological classification of tumours, 19","author":"F.K. Mostofi","year":"1973","unstructured":"Mostofi FK, Sorbin LH, Torloni H (1973) Histological typing of urinary bladder tumours. International histological classification of tumours, 19. Geneva: World Health Organization"},{"key":"130_CR16","volume-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer","year":"1997","unstructured":"American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th Edn. New York: Lippincott-Raven","edition":"5th Edn."},{"key":"130_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/annonc\/mdg002","volume":"14","author":"P. Gazzaniga","year":"2003","unstructured":"Gazzaniga P, Gradilone A, Giuliani L et al (2003) Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14:85\u201390","journal-title":"Ann Oncol"},{"key":"130_CR18","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1074\/jbc.M106643200","volume":"277","author":"W.H. Hoffman","year":"2002","unstructured":"Hoffman WH, Biade S, Zilfou JT et al (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247\u20133257","journal-title":"J Biol Chem"},{"key":"130_CR19","first-page":"784","volume":"54","author":"C.H. Spruck","year":"1994","unstructured":"Spruck CH, Ohneseit PF, Gonzalez-Zulueta M et al (1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784\u2013788","journal-title":"Cancer Res"},{"key":"130_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.11049","volume":"105","author":"L. Santos","year":"2003","unstructured":"Santos L, Amaro T, Costa C et al (2003) KI-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 105:267\u2013272","journal-title":"Int J Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-007-0130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-007-0130-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-007-0130-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:50:39Z","timestamp":1559447439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-007-0130-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s12094-007-0130-4","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}